Metharbital

Metharbital
Clinical data
Other names	Endiemal, metharbitone, methobarbitone
Routes of; administration	By mouth (tablets)
ATC code	N03AA30 (WHO) ;
Legal status
Legal status	CA: Schedule IV; US: Schedule III;
Identifiers
	IUPAC name 5,5-Diethyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione;
CAS Number	50-11-3 ;
PubChem CID	4099;
IUPHAR/BPS	7230;
DrugBank	DB00463 ;
ChemSpider	3957 ;
UNII	02OS7K758T;
KEGG	D01382 ;
ChEMBL	ChEMBL450 ;
CompTox Dashboard (EPA)	DTXSID6023280 ;
ECHA InfoCard	100.000.011
Chemical and physical data
Formula	C9H14N2O3
Molar mass	198.222 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1N(C(=O)NC(=O)C1(CC)CC)C;
	InChI InChI=1S/C9H14N2O3/c1-4-9(5-2)6(12)10-8(14)11(3)7(9)13/h4-5H2,1-3H3,(H,10,12,14) ; Key:FWJKNZONDWOGMI-UHFFFAOYSA-N ;
	(verify)

Metharbital was patented in 1905 by Emil Fischer working for Merck.^[2] It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy.^[3]^[4] It has similar properties to phenobarbital.

Other namesEndiemal, metharbitone, methobarbitone^[1]

Quick facts Clinical data, Other names ...

Close

History

Clinical data


Other names	Endiemal, metharbitone, methobarbitone^[1]
Routes of administration	By mouth (tablets)
ATC code	N03AA30 (WHO)
Legal status
Legal status	CA: Schedule IV US: Schedule III
Identifiers
IUPAC name 5,5-Diethyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number	50-11-3^Y
PubChem CID	4099
IUPHAR/BPS	7230
DrugBank	DB00463^Y
ChemSpider	3957^Y
UNII	02OS7K758T
KEGG	D01382^Y
ChEMBL	ChEMBL450^Y
CompTox Dashboard (EPA)	DTXSID6023280
ECHA InfoCard	100.000.011
Chemical and physical data
Formula	C₉H₁₄N₂O₃
Molar mass	198.222 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C1N(C(=O)NC(=O)C1(CC)CC)C
InChI InChI=1S/C9H14N2O3/c1-4-9(5-2)6(12)10-8(14)11(3)7(9)13/h4-5H2,1-3H3,(H,10,12,14)^Y Key:FWJKNZONDWOGMI-UHFFFAOYSA-N^Y
(verify)